Latest Health News from Duke Medicine News and Communications
Search News
For Journalists
Reporters & producers can visit Duke Medicine News and Communications for contact information.
CDC Confirms Four New Cases of Oseltamivir (Tamiflu)-Resistant H1N1
Nov. 20, 2009
Tests performed by the Centers for Disease Control and Prevention (CDC) at the request of infectious disease experts at Duke University Medical Center have confirmed this week that isolates from four patients with H1N1 influenza at Duke University Hospital over the past six weeks were found to be resistant to oseltamivir (Tamiflu). Two oseltamivir-resistant H1N1 isolates were reported in western North Carolina earlier this summer.
New Heart Pump Extends Life of Heart Failure Patients
Nov. 17, 2009
In one of the largest studies conducted to date, a new heart pump, or left ventricular assist device (LVAD), demonstrated a four-fold increase in the survival of advanced heart failure patients without a stroke or device failure.
Duke Heart Center Receives American College of Cardiology Foundation Performance Achievement Award
Nov. 17, 2009
Duke Heart Center at Duke University Hospital (DUH) has received the American College of Cardiology Foundation’s NCDR ACTION Registry–GWTG Gold Performance Achievement Award for 2009 -- one of only 121 hospitals nationwide to do so.
Duke Researchers Find Rapid Maturation of Neurons at Birth
Nov. 17, 2009
At the moment a newborn switches from amniotic fluid to breathing air, another profound shift occurs: nerve cells in the brain convert from hyperexcitability to a calm frame against which outside signals can be detected.
New Test May Predict Heart Disease Events and the Effect of Weight Loss on Insulin Resistance
Nov. 17, 2009
Chemical fingerprints produced by the body’s normal metabolic processes predict who will suffer cardiovascular events and who will benefit from weight loss by reduction of insulin resistance, according two new studies by researchers at Duke University Medical Center.
One-Third of Maximum Radiation Dose Obtained in Single Heart Attack Hospitalization
Nov. 16, 2009
Acute heart attack patients receive an average dose of radiation that is 30 percent of the recommended annual limit -- equal to 725 chest X-rays -- during an average hospital admission, according to researchers at Duke University Medical Center.
New Anti-Clotting Medication Not More Effective than Standard Care; Hint of Other Clinical Benefits
Nov. 16, 2009
Two large studies confirmed that an investigational, reversible anti-clotting medication failed to show greater effectiveness than clopidogrel or a placebo for patients undergoing a procedure to open blocked coronary arteries, according to researchers at the Duke Clinical Research Institute. However, some data in the study suggest the potential for a different, more targeted use for cangrelor.
Duke Clinical Research Institute to Begin Nationwide Outcomes Study of Atrial Fibrillation Treatment
Nov. 11, 2009
To address the need for more information to help improve the care of patients with atrial fibrillation, the Duke Clinical Research Institute (DCRI) is launching the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). ORBIT-AF is a prospective, longitudinal, observational study, scheduled to begin in December, which will evaluate treatment patterns and the subsequent outcomes of 10,000 patients in the United States.
Medanta – The Medicity and Duke Medicine Partner to Create Groundbreaking Global Translational Research Facility
Nov. 10, 2009
New Delhi, India -- Medanta – The Medicity and Duke Medicine today signed a joint venture agreement with the vision to launch the Medanta Duke Research Institute (MDRI), a world class early phase clinical research facility at Medanta.
Duke University and Jubilant Organosys Announce Intent to Enter Global Research and Drug Development Partnership
Nov. 10, 2009
Duke University and Jubilant Organosys partner to advance both organizations’ mutual commitment to reducing global health disparities.
Nov. 20, 2009
Tests performed by the Centers for Disease Control and Prevention (CDC) at the request of infectious disease experts at Duke University Medical Center have confirmed this week that isolates from four patients with H1N1 influenza at Duke University Hospital over the past six weeks were found to be resistant to oseltamivir (Tamiflu). Two oseltamivir-resistant H1N1 isolates were reported in western North Carolina earlier this summer.
New Heart Pump Extends Life of Heart Failure Patients
Nov. 17, 2009
In one of the largest studies conducted to date, a new heart pump, or left ventricular assist device (LVAD), demonstrated a four-fold increase in the survival of advanced heart failure patients without a stroke or device failure.
Duke Heart Center Receives American College of Cardiology Foundation Performance Achievement Award
Nov. 17, 2009
Duke Heart Center at Duke University Hospital (DUH) has received the American College of Cardiology Foundation’s NCDR ACTION Registry–GWTG Gold Performance Achievement Award for 2009 -- one of only 121 hospitals nationwide to do so.
Duke Researchers Find Rapid Maturation of Neurons at Birth
Nov. 17, 2009
At the moment a newborn switches from amniotic fluid to breathing air, another profound shift occurs: nerve cells in the brain convert from hyperexcitability to a calm frame against which outside signals can be detected.
New Test May Predict Heart Disease Events and the Effect of Weight Loss on Insulin Resistance
Nov. 17, 2009
Chemical fingerprints produced by the body’s normal metabolic processes predict who will suffer cardiovascular events and who will benefit from weight loss by reduction of insulin resistance, according two new studies by researchers at Duke University Medical Center.
One-Third of Maximum Radiation Dose Obtained in Single Heart Attack Hospitalization
Nov. 16, 2009
Acute heart attack patients receive an average dose of radiation that is 30 percent of the recommended annual limit -- equal to 725 chest X-rays -- during an average hospital admission, according to researchers at Duke University Medical Center.
New Anti-Clotting Medication Not More Effective than Standard Care; Hint of Other Clinical Benefits
Nov. 16, 2009
Two large studies confirmed that an investigational, reversible anti-clotting medication failed to show greater effectiveness than clopidogrel or a placebo for patients undergoing a procedure to open blocked coronary arteries, according to researchers at the Duke Clinical Research Institute. However, some data in the study suggest the potential for a different, more targeted use for cangrelor.
Duke Clinical Research Institute to Begin Nationwide Outcomes Study of Atrial Fibrillation Treatment
Nov. 11, 2009
To address the need for more information to help improve the care of patients with atrial fibrillation, the Duke Clinical Research Institute (DCRI) is launching the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). ORBIT-AF is a prospective, longitudinal, observational study, scheduled to begin in December, which will evaluate treatment patterns and the subsequent outcomes of 10,000 patients in the United States.
Medanta – The Medicity and Duke Medicine Partner to Create Groundbreaking Global Translational Research Facility
Nov. 10, 2009
New Delhi, India -- Medanta – The Medicity and Duke Medicine today signed a joint venture agreement with the vision to launch the Medanta Duke Research Institute (MDRI), a world class early phase clinical research facility at Medanta.
Duke University and Jubilant Organosys Announce Intent to Enter Global Research and Drug Development Partnership
Nov. 10, 2009
Duke University and Jubilant Organosys partner to advance both organizations’ mutual commitment to reducing global health disparities.
About This Page
URL: http://www.dukehealth.org/HealthLibrary/News
